Explain how to handle ethical issues related to patient access to experimental therapies outside standard care.

• A. Automatically enroll all patients in experimental therapies.
• B. Withhold information about experimental therapies.
• C. Provide clear information, assess risks and benefits, ensure voluntary informed consent, and involve ethics or oversight when applicable.
• D. Approve experimental therapies without consent.

Answer: (C)

Handling ethical issues around access to experimental therapies outside standard care requires honoring patient autonomy while safeguarding safety through transparent information and appropriate oversight. The best approach is to provide clear, honest information about what is known and unknown about the experimental therapy, the potential risks and benefits, and any alternatives, so the patient can make an informed choice. Assess how the risks and potential benefits align with the patient’s values and goals, check that the patient understands the information, and obtain voluntary informed consent without coercion. Involve ethics consultation or oversight bodies when applicable to review the case, ensure fair access where possible, and establish plans for monitoring, reporting adverse effects, and avenues for withdrawal if desired.

Why the other options don’t fit: Automatically enrolling patients removes their right to decide and can expose them to unknown harm; withholding information denies consent and trust; approving without consent violates fundamental rights and professional standards.